Interactive Panel Discussion & Q&A: Driving the Next Generation of Oncology Diagnostics & Therapeutics: We Cannot Do It Alone

Time: 7:15 pm
day: Driving the Next Generation of Oncology Diagnostics & Therapeutics


  • The latest biomarker and CDx strategies to guarantee broader patient adoption of oncology therapeutics across the globe
  • How biopharma is integrating NGS into clinical development to achieve long-term strategic stability and clinical success in oncology therapeutic development
  • How Illumina is working to bridge the different ecosystems across the cancer care continuum, from early innovation, clinical development, and patient care to drive the latest innovative concepts into marketable therapeutics and diagnostics, and to deliver future proof CDx solutions to biopharma’s oncology pipelines